Fact Sheet: President Donald J. Trump Announces Largest Developments to Date in Bringing Most-Favored-Nation Pricing to American Patients

Fact sheetPublished 25/12/19Open the original

Summary

President Trump announces most-favored-nation pricing agreements with nine drug makers: Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead, GSK, Merck, Novartis and Sanofi. Gilead's hepatitis C drug Epclusa falls from $24,920 to $2,425 on TrumpRx.

By industry

Healthcare & Drug Pricing1 trading day−0.2%p15 stocks5 trading days−0.0%p15 stocks20 trading days+2.2%p15 stocks
“announced nine new agreements with major pharmaceutical companies to lower prescription drug prices”

Day by day after the announcement

Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
Day	Healthcare & Drug Pricing stocks	S&P 500
25/12/18	0.0%	0.0%
25/12/19	+0.6%	+0.8%
25/12/22	+1.3%	+1.3%
25/12/23	+1.2%	+1.7%
25/12/24	+1.8%	+2.1%
25/12/26	+2.1%	+2.1%
25/12/29	+1.9%	+1.7%
25/12/30	+1.7%	+1.6%
25/12/31	+1.3%	+0.9%
26/01/02	+1.8%	+1.1%
26/01/05	+1.3%	+1.7%
26/01/06	+2.9%	+2.4%
26/01/07	+3.5%	+2.1%
26/01/08	+2.8%	+2.1%
26/01/09	+2.1%	+2.7%
26/01/12	+2.5%	+2.8%
26/01/13	+2.4%	+2.6%
26/01/14	+3.5%	+2.0%
26/01/15	+3.8%	+2.4%
26/01/16	+2.9%	+2.3%
26/01/20	+2.5%	+0.3%

Stocks it names

AmgenAMGN

Korean stocks in these industries

Samsung Biologics 207940
Celltrion 068270
SK Biopharmaceuticals 326030

Trades in these industries around the announcement

Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.

Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$128.2M
120,016 sh
$128.2M
Filed 25/11/25
Traded 25/11/24
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$101.4M
96,516 sh
$101.4M
Filed 25/11/20
Traded 25/11/19
John G. MorikisDirector
BuyJohnson & Johnson
Buy
Johnson & Johnson
JNJ
$257.7K
1,250 sh
$257.7K
Filed 25/12/01
Traded 25/11/26
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$45.2M
40,956 sh
$45.2M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$38M
34,434 sh
$38M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$30.2M
28,768 sh
$30.2M
Filed 25/11/20
Traded 25/11/19
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$26.9M
24,362 sh
$26.9M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$25.3M
23,916 sh
$25.3M
Filed 25/11/24
Traded 25/11/21
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$23.2M
21,042 sh
$23.2M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$22.8M
20,668 sh
$22.8M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$22.5M
20,447 sh
$22.5M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$22.2M
21,107 sh
$22.2M
Filed 25/11/20
Traded 25/11/19
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$19.9M
18,254 sh
$19.9M
Filed 25/11/26
Traded 25/11/25
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$18.4M
16,650 sh
$18.4M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$17.7M
16,845 sh
$17.7M
Filed 25/11/21
Traded 25/11/20
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$16.4M
14,937 sh
$16.4M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$15.2M
13,701 sh
$15.2M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$15.1M
14,105 sh
$15.1M
Filed 25/11/25
Traded 25/11/24
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$14.7M
13,247 sh
$14.7M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$14.6M
13,820 sh
$14.6M
Filed 25/11/20
Traded 25/11/19